EU Policy on EDCs | Breast Cancer UK

EU Policy on EDCs

An Endocrine Disrupting Chemical (EDC) or Endocrine Disruptor (ED) is any chemical that can interfere with normal hormone functions in humans. There is growing scientific concern that EDCs could be linked to an increased risk of breast cancer.

EDCs are regulated at the EU level, but this regulation is complex and inconsistent. While we have seen some progress in recent years, EDCs continue to be used widely across Europe in a range of different products.

The EU Commission has developed criteria for identifying EDCs, which was finalised and adopted in 2018 after several years of delay. Despite vigorous campaigning from scientists and charities the criteria are not ideal, as the burden of proof required to identify a substance as an EDC is too high. But it is a start.

Currently the criteria apply to EDCs used a in plant protection product (PPPs) and biocides The Commission is now developing a new EDC strategy that will cover areas such as toys, cosmetics and food packaging.

Breast Cancer UK is working with partners in Europe to press for a robust and comprehensive EDC strategy which promotes the phase out of potential and suspected EDCs and their replacement with safer alternatives.

Breast Cancer UK policy and position papers

Consultation Responses

Letters and joint statements

Did you find this article useful?

(4.0/5, based on 1 review)

Help us prevent breast cancer Make a donation now